MADISON, Wis. — The Wisconsin Chamber Orchestra (WCO) today announced that Exact Sciences Corp. will be the exclusive sponsor of the 2015 season of Concerts on the Square.

"This partnership between a company that's committed to Madison and a great Madison tradition is truly a gift to our community," said the WCO's Executive Director Mark Cantrell. "On Wednesday evenings throughout the summer 180,000 people come together for Concerts on the Square. The support of Exact Sciences will only enhance their experience this season."

Cantrell pointed out that the support of Exact Sciences - the manufacturer of Cologuard, the only FDA-approved, non-invasive colon cancer screening test - will help expand the community's understanding for the importance of advanced cancer screening.

"Madison summers are unique because of community gatherings like Concerts on the Square," said Kevin Conroy, chairman and CEO of Exact Sciences. "Exact Sciences is committed to our hometown and ensuring that all of the things that make Madison a great place to work and live are here for everyone to enjoy. As we continue to grow as a company, we recognize that our success is only as strong as the community we share."

Concerts on the Square will take place every Wednesday evening at 7:00 p.m. CT from June 24-July 29, 2015 on the Capitol Square.

Wisconsin Chamber Orchestra's Concerts on the Square

About the Wisconsin Chamber Orchestra

The Wisconsin Chamber Orchestra, led by Maestro Andrew Sewell, is a vibrant and thriving professional orchestra dedicated to connecting its audiences to the power of music. The WCO performs approximately 25 concerts per year, including Concerts on the Square®, Masterworks, Holiday Pops, Handel's Messiah, Youth Concerts, and other performances across the state.

About Exact Sciences

Exact Sciences Corp. (NASDAQ: EXAS) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, follow us on Twitter @ExactSciences or find us on Facebook.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150515005042/en/

Wisconsin Chamber Orchestra
Sue Ellen Maguire
608-257-0638
Director of Marketing
sueellenmaguire@wcoconcerts.org

or

Exact Sciences Corp.
J.P. Fielder
608-210-5220
Senior Director of Corporate Communications
jpfielder@exactsciences.com

Source: Exact Sciences Corp.